Needham Maintains Buy on RxSight, Raises Price Target to $34
Portfolio Pulse from richadhand@benzinga.com
Needham analyst David Saxon maintains a Buy rating on RxSight (NASDAQ:RXST) and raises the price target from $27 to $34.
July 12, 2023 | 9:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst David Saxon maintains a Buy rating on RxSight and raises the price target from $27 to $34. This could potentially lead to an increase in the stock's price.
The raised price target by Needham analyst indicates a positive outlook for RxSight. This could potentially attract more investors, leading to an increase in demand for the stock and subsequently, an increase in its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100